chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccinated on Friday, by Saturday the patient vomited once, spiked a fever to 104 and had a febrile seizure.  Pt taken to ER, blood drawn and released home.  Pt on Tylenol and Motrin at time of f/up.
She was diagnosed to have stage 4 lung cancer after she got the first dose; This spontaneous case was reported by a patient and describes the occurrence of LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV (She was diagnosed to have stage 4 lung cancer after she got the first dose) in a female patient of an unknown age who received mRNA-1273.815 (SPIKEVAX 2023-2024) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form. On an unknown date, the patient experienced LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV (She was diagnosed to have stage 4 lung cancer after she got the first dose) (seriousness criterion medically significant). At the time of the report, LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV (She was diagnosed to have stage 4 lung cancer after she got the first dose) had not resolved.        The action taken with mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown) was unknown.   For mRNA-1273.815 (SPIKEVAX 2023-2024) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Patient stated that she had stage 4 lung cancer and needs to have the Moderna vaccine shot but cannot seem to find any place near her that carries it. Her previous vaccines were all Moderna.  Treatment information was not provided.  Company Comment: This is a spontaneous case concerning a female patient of unknown age, with no reported medical history, who experienced the serious (due to medically significant) unexpected, event of Lung carcinoma cell type unspecified stage IV, which occurred after the first dose of Spikevax (COVID-19 Vaccine, mRNA) 2023-2024 Formula. The outcome was reported as not recovered. The company considered the event as not related to the vaccine due to the nature of the event, lack of biological plausibility and known safety profile of the vaccine. No further clinical information was available for medical review. The benefit-risk relationship of Spikevax (COVID-19 Vaccine, mRNA) 2023-2024 Formula is not affected by this report.
Since the vaccine (Maderna), magnets stick to my body all over. Not just the injection site. I also have no antibodies since having the vaccination.
Patient up to date on COVID vaccinations who admitted to hospital with NSTEMI who also tested detected for COVID (mild symptoms of congestion).  Provider discharge note below:  "80 YO male who was admitted for NSTEMI, he was started on IV heparin. He underwent LHC which showed multivessel disease , multiple overlapping stents, culprit lesion most likely diagonal branch small caliper vessel. He was recommended medical management. Added imdur. His blood pressures have been slightly softer and bradycardic. His lisinopril was changed to 10 mg daily and lopressor to daily rather than BID. Patient had been stable, discussed with cardiology. Will follow up outpatient with cardio and PCP."
An expired Covid-19 pfizer vaccine was administered to the patient on 4/18/22.  The vaccine expired on 4/18/22 at 10am.  The error was discovered on 4/29/22. On 5/3, a COVID-19 Vaccine temperature related enquiry form was filled out and emailed to Pfizer.  On 5-9-22 at 7:51am, we received an email from Pfizer's quality team stating they do not have stability data to support our excursion from prescribed storage conditions. We have reached out to our affected patients informing them of the situation and offered to revaccinate them if they choose to. Spoke with patient on 5/9 and patient does not plan to get revaccinated.
Dizziness, with head back, or strong eye movement. could me settled when eyes closed and normal head position. Some balance problems when getting up from sitting position. Slowly less over two weeks time. Still some problems.
Headache about 3-4 hours post vaccine  gone 45 minutes post acetaminophen; sore arm later that day.  Acetaminophen.
Dysphagia. Lost the ability to swallow food for 4-5 months. Could only swallow clear liquids. Lost 40 pounds. I was health up until I had this vaccine and then I lost the ability to swallowed. Started by choking on a medication and then I could not swallow food. Everything else ruled out. I had multiple test done with gastroenterology. It was neurological/ strange reaction.
This spontaneous report as received from a licensed vocational nurse refers to a male patient of unknown age. There was no medical history, drug reactions/allergies and concomitant medication provided. On 06-MAY-2015, the patient was vaccinated with a improperly stored dose of (Merck) PROQUAD (route subcutaneous, dose was not reported, lot # reported as K020740, expiration date 30-APR-2016) as patient's second dose in the series. There was no adverse event reported. Additional information has been requested.
Dermatographia developed 1 month after final dose. Itchey skin, hives develop when scratched. I've never had any allergies for all of my life.
Rt arm was swollen and painful the day after the vaccine was administered 80% R upper arm was tender.
Information has been received from a registered nurse concerning a 16 year old female who on 16-AUG-2007 was vaccinated with a third dose of Gardasil.  On 16-AUG-2007 the patient experienced dizziness and passed out for 10 seconds while still in the office.  The patient was given some juice.  On 16-AUG-2007 the patient recovered.  Additional information has been requested.
Received the treatment on April 8th around 4p. I came home with no thought of the vaccination. I abesent-mindedly tested my BP with an automatic cuff on the same arm around 6p. Around 8p my arm started to lose it's strength. In the middle of the night while sleeping, I woke up in pain. My arm felt like it had been broken with a significant amount of nerve damage. (It was a funny bone feeling from arm, elbow and wrist) It was throbbing and my feeling was numb from my shoulder to wrist. I started taking my husband's hydrocodone to sleep and continue daily function. Each day, my arm improved, however, I was no longer able to lift or move it with real intent. (It was like it was paralyzed)The weirdest things that my hand (fist) was never affected. I could use it as long as I did not have to move my arm or bend my elbow. The pain and lack of movement lasted 1.5 weeks. We I walked my arm appeared dead like a recent stroke victim. I went to the doctor the 17th of April( soonest appointment) . By then I was no longer taking pain pills but I did not have full range of motion. Now, April 27th, I can lift my arm up with no pain but my strength is still weak. At one point I thought the damage might be permanent, but every day the pain and the limitations seem to improve.
Dizziness, tremulousness, seizures/convulsions started 12/10/2021 and have not ceased to date
Student reported symptoms of diaphoresis, dyspnea, and transient chest pain and muscle pain one hour after receiving MMR/Hep B vaccines. Evaluated in office, B/P slightly elevated, fever for 30-45 minutes, refused ER treatment at time. Symptoms resolved and later evaluated at ER.
VERY SICK; COULD NOT GET OUT OF BED FOR ONE DAY; Fever; Achy; Inflammation; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (VERY SICK), PAIN (Achy), INFLAMMATION (Inflammation), MOBILITY DECREASED (COULD NOT GET OUT OF BED FOR ONE DAY) and PYREXIA (Fever) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect products included non-company products UPADACITINIB (RINVOQ) for Rheumatoid arthritis and INFLUENZA VACCINE for an unknown indication.    Concurrent medical conditions included Rheumatoid arthritis.   In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Oct-2021, the patient received dose of INFLUENZA VACCINE (unknown route) at an unspecified dose. On 01-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started UPADACITINIB (RINVOQ) (Subcutaneous) at an unspecified dose. On 01-Nov-2021, the patient experienced ILLNESS (VERY SICK) and MOBILITY DECREASED (COULD NOT GET OUT OF BED FOR ONE DAY). In November 2021, the patient experienced PAIN (Achy), INFLAMMATION (Inflammation) and PYREXIA (Fever). The patient was treated with PREDNISONE for Inflammation, at an unspecified dose and frequency. In 2021, ILLNESS (VERY SICK) had resolved. On 01-Nov-2021, MOBILITY DECREASED (COULD NOT GET OUT OF BED FOR ONE DAY) had resolved. At the time of the report, PAIN (Achy) and PYREXIA (Fever) outcome was unknown and INFLAMMATION (Inflammation) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Oct-2021, Blood test: increased Sedimentation rate.         Concomitant product use was not provided by the reporter.  On 28-Oct-2021, blood work showed increased sedimentation rate. On 28 Oct 2021 she had taken flu shot. In Nov-2021, the patient was achy, had fever, and inflammation. On 01-Nov-2021, the patient got very sick after covid booster and could not get out of bed for one day. In 2021, the very sick after covid booster resolved. She received a shot of prednisone and her inflammation was better. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.     This case was linked to MOD-2021-623528, MOD-2021-628641 (Patient Link).   Reporter did not allow further contact
had Guillain Barre after receiving the flu shot; This case was reported by a nurse via call center representative and described the occurrence of guillain barre syndrome in a patient who received Flu unspecified (Influenza vaccine) for prophylaxis.   On an unknown date, the patient received Influenza vaccine at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   It was unknown if the reporter considered the guillain barre syndrome to be related to Influenza vaccine.  Additional details were provided as follows: The age at vaccination was not reported. After receiving Influenza vaccine, the patient had guillain barre syndrome.
The day after I woke up with worse arthritis than normal and proceeding to get worse daily for about 8 weeks. The height of the pain was in mid May at a time when I couldn't bend either knee to get into a car (like before knee replacement.) I had to use my hands to pick up my legs to get into the car and then use my hands to bend the knee. Luckily this was only one day like this. During this time I felt like my hormones were acting up and I was in a sad place.
This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received Covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, 1 total, administered on unspecified date in MAY-2021 or JUN-2021 (exact date unknown) for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. It was unknown whether patient experienced any adverse event following vaccination with Covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient additionally received non-company suspect vaccine included: Pfizer BioNTech Covid-19 vaccine (tozinameran) (dose number in series 2) (form of admin, route of admin, and batch number were not reported, expiry: unknown) dose was not reported, administered on DEC-2021 for prophylactic vaccination. On an unspecified date in JUN-2022, the patient tested positive for COVID-19 by rapid test (dose number in series 2). Laboratory data included: COVID-19 rapid POC test Positive. The action taken with Covid-19 vaccine ad26.cov2.s, and tozinameran was not applicable. The outcome of Covid-19 test positive was not reported. This report was non-serious. This case was associated with a product quality complaint 90000241367.
p/ pt recv vax approx 5 mos later pt devel varicella like rash w/20-30 lesions & pt afebrile
body started to feel funny; real woozy; Headache/it hurts from her nose to  between her forehead/woosy headache; sore arm; just not feeling right; dizzy, like she was walking funny; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200284522 (Pfizer).  A 43 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Feb2022 12:20 (Lot number: FM0698) at the age of 43 years as dose 1, 0.3 ml single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Hepatitis vaccine (had 1 year or 2 ago at the latest. It was Hepatitis vaccine and she did perfectly fine with that), for Immunization. The following information was reported: FEELING ABNORMAL (non-serious) with onset 13Feb2022, outcome "not recovered", described as "body started to feel funny"; DIZZINESS (non-serious) with onset 13Feb2022, outcome "recovering", described as "real woozy"; HEADACHE (non-serious) with onset 13Feb2022, outcome "unknown", described as "Headache/it hurts from her nose to  between her forehead/woosy headache"; PAIN IN EXTREMITY (non-serious) with onset 13Feb2022, outcome "not recovered", described as "sore arm"; MALAISE (non-serious) with onset 13Feb2022, outcome "not recovered", described as "just not feeling right"; DIZZINESS (non-serious) with onset 13Feb2022, outcome "unknown", described as "dizzy, like she was walking funny". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of feeling abnormal, dizziness, headache, pain in extremity, malaise, dizziness.  Additional information: She stated that event Real woozy it is off and on and not to the point she is passing out, it is just making her feel funny. The strange feeling, like if you walk funny. Caller states it is in-between improved and persisting. She stated that Headache, it is not like the top of the head headache feeling, it hurts from her nose to between her forehead. States it is off and on. Sore arm: Started a couple of hours after the shot. States she was perfectly fine before this. She had no underlying condition. She never had to go to a hospital. Then she took this shot, and this started.   No follow-up attempts are possible. No further information is expected.
She got vaccinated, got Covid three days later; Having a lot of stiff joints and joint pain; Having a lot of stiff joints and joint pain; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient got COVID three days later after she got vaccinated on an unspecified date. On an unspecified date in Jul2021 (also reported as now), the patient was having a lot of stiff joints and joint pain. It was reported that the patient was wondering if this was a side effect of the vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test: positive. The outcome for the events was unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.
Heart palpitations, heart flutter, and anxiety after about 3 days after first dose. Heart flutters continued on and off for one week. Heart flutters and palpation 3 hours after second dose. Chest felt very heavy. Went in to see primary care Dr. who stated that a brief PAC was heard. EKG performed. No structural issues noted. Sources of magnesium has improved issue.
Three to four days after the second dose I was experiencing joint pain that went to being severe. I have had gout in the past but I have it extremely frequently since having been vaccinated. I can only compare this to a gout attack. It's more frequent than ever after the second shot I had it go from the ball of my foot to my ankle and even to my wrist.  This has never ever occurred. All of this came after the second shot.
1. fever, body aches/Pt states she has had phlegm in her throat X 1 month, with sneezing, states she has tried OTC sinus medication and it has not helped. She feels the mucus has now gone into her chest and started with fever and bodyaches yesterday    Pt self reported completing PFIZER COVID vaccine series at the beginning of May. I was unable to pull vaccination information.
Initial report was received 19 November 2008 from a health care professional. A six-month old male patient had received a dose of FLUZONE SV and IPOL (manufactured by sanofi pasteur), PREVNAR (manufactured by Wyeth), and a dose of DTAP, HEP B, and HIB vaccines (manufactures not reported) on 06 February 2006 and an unspecified amount of time later, he developed hives. The lot numbers, routes and sites of vaccination were not reported. It was unknown of any corrective treatments were required for this event. Concurrent illness at the time of vaccination, concomitant medications, and pre-existing medical conditions were reported as unknown. According to the reporter, the patient had been seen by an allergist and had recovered from the event. Documents held by sender: None
High heart rate day after with a  headache. Day 6, elevated heart rate, heart palpitations, headache, stomach pain, muscle and joint pain, enlarged lymph node in left armpit hurts, chills. Day 7 stomach pain has worsened, and still have heart palpitations and joint and muscle pain and chills.
pt had difficulty breathing, was was coughing and feeling abnormal.   She vomited and lost consciousness and epipen was administered.  She was feeling much better by the time the paramedics arived
The shot location showed a red buffy skin ring 4cm in length. It almost looked like the shape of ringworm however it is not itching. The area feels hot not normal temp.
Patient presented to the office on the A.M. of 06/12/2008 with redness, swelling and warmth to the back of left arm.  The area measured 10cmx12cm. Mom stated that it started last pm 06/11/2008.  Mom had circled the area with a marker last pm it measured approximately 8cmx10cm.  Patient was seen by Dr.  at 11:50am on 6/12/2008 and treated for cellulitis d/t vaccine reaction with Cleocin 300mg by mouth every 8 hrs for 7 days.
First day my arm was a little red and sore which lasted 24 hours.  After day 8 I now have a red, hot, hard, baseball sized itchy rash on my left arm at the injection site.  I'm extremely tired but haven't had any other side effects aside from this itchy rash.  It has grown in size every day and seems to be getting bigger still after 2 days.  I have been taking Advil, Benedryl, and putting Cortisone cream/Aloe with lidocane on the injection site which seems to help for a few hours.  Ice helps as well.  It is just really annoying, like I was stung by a bee/wasp on the arm.
Pt brought in to ED 4/14/2021 0939 unresponsive, resuscitation attempt unsuccessful.   During this event, family stated that pt received a COVID-19 vaccination last week, with a reaction that required medical treatment afterwards.  Family believed this was through the Facility, but last Facility contact was a 4/2/21 ED visit for dyspnea.  Pt had also mentioned getting the vaccine "in the community".    Family provided info that pt had been working at University, and they believed the vaccine was obtained there as part of his employment.   Waiting for a return call to confirm or deny this vaccination site.
Patient was sitting in the post-IMZ waiting area for the 15 minute observation period after his second dose of Moderna (COVID vaccine). About 10-15 minutes later his wife came and told me the patient didn't feel well. I went to check on him; he was in a cold sweat, dizzy, lightheaded, and feeling faint. I got him some water and wet paper towels to put on the back of his neck. I checked on him a minute or two later and he wasn't feeling better (he looked a little worse). At this point his speech had slowed some because he was having a hard time preventing himself from fainting (he kept pausing his sentences when he pulled himself back awake). He was nauseated (said he needed to dry heave) and had dry mouth. I called a code white (injury) on the walkie and got the patient an ice pack from our freezer for his neck. When management arrived I brought them up to speed. As they started checking in with him, it became apparent he felt even worse. At this point management and I agreed to call emergency services to have someone come check him out. I let the patient know we were going to get someone to come take a look at him and see if he needed to go to the hospital. Management brought our bench over to the patient so he could slide over from his chair and have more room (patient is large and was struggling to balance in the smaller chair). I held his outstretched (to me) arm and helped him scoot over to the bench. Soon after EMS arrived and we handed off to them. During this I was also keeping an eye on/in the pharmacy since I was the only pharmacist.
Patient had the vaccine in January and February but had the booster October 5.  Admitted with chest pain.
SARS 2; SARS 2; MS; This is a spontaneous report from a contactable consumer (patient's friend). A female patient of an unspecified age received bnt162b2 (COMIRNATY, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date (unknown age at time of vaccination) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient's friend reported: "Saw my doctor on the 19th and showed him the lesions on my lower, left, abdomen, and he said nothing as to why the lesions appeared after the first Pfizer injection, which was about one or two days. As those of us who do research the FDA did not follow their rules in approving any drug for wide consumption. So, these new vaccines never were tested for years, and they cannot save older citizens with underlying heath conditions. I also lost a friend (the patient). She had MS and in ten days she was called home, or died of SARS 2." The outcome of MS was unknown. The patient died on an unspecified date. It was unknown if an autopsy was performed. The cause of death was SARS 2.  Information on the lot/batch number has been requested.; Reported Cause(s) of Death: SARS 2; SARS 2